VanEck Biotech ETF (BBH)
NASDAQ: BBH
· Real-Time Price · USD
166.23
-0.62 (-0.37%)
At close: Aug 18, 2025, 3:59 PM
166.26
0.02%
After-hours: Aug 18, 2025, 04:10 PM EDT
-0.37% (1D)
| Bid | 156 |
| Market Cap | 340.25M |
| AUM | 351.55M |
| NAV | 166.89 |
| EPS (ttm) | 6.96 |
| PE Ratio (ttm) | 23.87 |
| Shares Out | 2.05M |
| Inception Date | Dec 20, 2011 |
| Ask | 175 |
| Volume | 7.27K |
| Open | 167.35 |
| Previous Close | 166.85 |
| Day's Range | 166.07 - 167.91 |
| 52-Week Range | 135.34 - 183.64 |
| Holdings | 25 |
| Expense Ratio | 0.35% |
About BBH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol BBH
Inception Date Dec 20, 2011
Provider Vaneck
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 70.79% of assets
| Name | Symbol | Weight |
|---|---|---|
| Amgen Inc. | AMGN | 15.23% |
| Gilead Sciences, Inc... | GILD | 13.31% |
| Vertex Pharmaceutica... | VRTX | 8.62% |
| Alnylam Pharmaceutic... | ALNY | 6.26% |
| Argenx Se | ARGX | 5.32% |
| Regeneron Pharmaceut... | REGN | 5.12% |
| Iqvia Holdings Inc. | IQV | 5.03% |
| Insmed Incorporated | INSM | 4.30% |
| Natera, Inc. | NTRA | 4.01% |
| Icon Public Limited ... | ICLR | 3.59% |
Dividends Dividend Yield 0.79%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 23, 2024 | $1.2517 | Dec 24, 2024 |
| Dec 18, 2023 | $0.7127 | Dec 22, 2023 |
| Dec 19, 2022 | $0.7488 | Dec 23, 2022 |
| Dec 20, 2021 | $0.3972 | Dec 27, 2021 |
| Dec 21, 2020 | $0.6079 | Dec 28, 2020 |
